Characteristics of the Diagnostic Groups
Characteristic . | Normal Controls . | MM . | MGUS . | Osteoporosis . |
---|---|---|---|---|
No. of subjects | 64 | 50 | 40 | 40 |
Sex (male/female) | 35/29 | 23/27 | 15/25 | 16/24 |
Age | ||||
Median | 65.5 | 67 | 66 | 70 |
Range | 39-84 | 28-87 | 40-86 | 51-83 |
Bone disease* (n) | ||||
None | 64 | 8 | 28 | 0 |
Osteoporosis | 0 | 11 | 12 | 40 |
Osteolysis | 0 | 14 | 0 | 0 |
Osteoporosis and osteolysis | 0 | 17 | 0 | 0 |
Vertebral fractures | 0 | 24 | 7 | 40 |
Plasma cell content of the bone marrow (%)† | ||||
Median | ND | 50 | 5 | ND |
Range | 5-85 | 0-20 | ||
Serum creatinine (μmol/L) | ||||
Median | 88.4 | 88.4 | 79.5 | 88.4 |
Range | 61.8-150.2 | 36.2-344.7 | 61.8-132.6 | 44.2-150.2 |
Serum calcium (mmol/L) | ||||
Median | 2.42 | 2.34 | 2.34 | 2.42 |
Range | 2.17-2.59 | 1.99-3.52 | 1.93-2.60 | 2.27-2.56 |
Serum β2-microglobulin (mg/L) | ||||
Median | 1.50 | 4.25 | 1.95 | 1.60 |
Range | 1.00-3.30 | 1.40-16.30 | 0.90-6.30 | 1.00-3.90 |
Characteristic . | Normal Controls . | MM . | MGUS . | Osteoporosis . |
---|---|---|---|---|
No. of subjects | 64 | 50 | 40 | 40 |
Sex (male/female) | 35/29 | 23/27 | 15/25 | 16/24 |
Age | ||||
Median | 65.5 | 67 | 66 | 70 |
Range | 39-84 | 28-87 | 40-86 | 51-83 |
Bone disease* (n) | ||||
None | 64 | 8 | 28 | 0 |
Osteoporosis | 0 | 11 | 12 | 40 |
Osteolysis | 0 | 14 | 0 | 0 |
Osteoporosis and osteolysis | 0 | 17 | 0 | 0 |
Vertebral fractures | 0 | 24 | 7 | 40 |
Plasma cell content of the bone marrow (%)† | ||||
Median | ND | 50 | 5 | ND |
Range | 5-85 | 0-20 | ||
Serum creatinine (μmol/L) | ||||
Median | 88.4 | 88.4 | 79.5 | 88.4 |
Range | 61.8-150.2 | 36.2-344.7 | 61.8-132.6 | 44.2-150.2 |
Serum calcium (mmol/L) | ||||
Median | 2.42 | 2.34 | 2.34 | 2.42 |
Range | 2.17-2.59 | 1.99-3.52 | 1.93-2.60 | 2.27-2.56 |
Serum β2-microglobulin (mg/L) | ||||
Median | 1.50 | 4.25 | 1.95 | 1.60 |
Range | 1.00-3.30 | 1.40-16.30 | 0.90-6.30 | 1.00-3.90 |